Copyright
©2011 Baishideng Publishing Group Co.
World J Cardiol. Jun 26, 2011; 3(6): 177-185
Published online Jun 26, 2011. doi: 10.4330/wjc.v3.i6.177
Published online Jun 26, 2011. doi: 10.4330/wjc.v3.i6.177
Features | Edwards SAPIEN XT | Medtronic core valve |
Manufacturer | Edwards Lifesciences | Medtronic |
Stent | Cobalt Chromium | Nitinol |
Valve leaflets | Bovine pericardium | Porcine pericardium |
Implantation | Balloon-expandable | Self-expandable |
Repositionable | No | Partially (prior to release) |
Retrievable | No | No |
Fixation | Aortic annulus | Aortic annulus and ascending aorta |
Available diameters (mm) | 23, 26 | 26, 29 |
Recommended annulus diameter (mm) | 18-25 | 20-27 |
Delivery system diameter | 18F (23) and 19F (26) | 18 F |
Minimum required arterial diameter (mm) | 6 | 6 |
Alternative to transfemoral | Transapical | Trans-subclavian |
Permanent pacemaker implantation | < 10% | 25%-35% |
Year published | Patients | Valve | Access | Procedural success (%) | 30-d mortality (%) | 1-yr mortality (%) | |
PARTNER EU[55] | 2010 | 61 | ES | TF | 91 | 8.1 | 21.3 |
SOURCE Registry[56] | 2010 | 463 | ES | TF | 95.2 | 6.3 | - |
PARTNER cohort B[11] | 2010 | 179 | ES | TF | - | 5 | 30.7 |
Rodés-Cabau et al[24] | 2010 | 168 | ES | TF | 90.5 | 9.5 | 25 |
PARTNER cohort A[12] | 2011 | 244 | ES | TF | - | 3.3 | 22.2 |
PARTNER EU[55] | 2010 | 69 | ES | TA | 91 | 18.8 | 51.7 |
SOURCE Registry[56] | 2010 | 575 | ES | TA | 92.7 | 10.3 | - |
Rodés-Cabau et al[24]1 | 2010 | 177 | ES | TA | 96.1 | 11.3 | 23 |
Wong et al[45]1 | 2010 | 60 | ES | TA | 98.3 | 18.3 | - |
PARTNER cohort A[12] | 2011 | 104 | ES | TA | - | 3.8 | 29 |
Grube et al[43] | 2008 | 1022 | CS | TF | 91.2 | 10.8 | - |
Piazza et al[57] | 2008 | 646 | CS | TF | 97.2 | 8 | - |
Avanzas et al[58] | 2010 | 108 | CS | 103 TF/5 TS | 98.1 | 7.4 | 17.7 |
Tamburino et al[27] | 2011 | 663 | CS | 599 TF/64 TS | 98 | 5.4 | 15 |
Name | Manufactured by | Country | Advantages and published experience |
AorTx™ | Hansen Medical | USA | Fully retrievable |
Direct Flow™ | Direct Flow Medical Inc | USA | Fully retrievable, inflatable fabric cuff around the valve that seals the aortic annulus. 6 patients implanted[59] |
Engager™ | Medtronic | USA | Specifically designed for transapical access. Easy positioning, better fixation (hooks). 30 implants in tricuspid position[53] |
HLT™ | Heart Leaflet Technologies | USA | ”Flow-through” configuration that does not create obstruction. No need for rapid pacing |
JenaValve™ | JenaValve | Germany | Repositionable, clipping of the native leaflets. No need for rapid pacing. First-in-man |
Lotus™ | Sadra Medical / Boston Scientific | USA | Fully repositionable, self-centreing, early leaflet function before final release. First-in-man[60] |
Paniagua™ | Endoluminal technology Research | USA | Low profile catheter. First retrograde implantation in the world[61] |
St Jude™ | St Jude Medical | USA | Additional binding in the ascending aorta. Early stages. No human implants yet |
ValveXchange™ | ValveXchange Inc | USA | Permanent support frame and exchangeable leaflet set. Early stages. No human implants yet |
- Citation: Salinas P, Moreno R, Lopez-Sendon JL. Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol 2011; 3(6): 177-185
- URL: https://www.wjgnet.com/1949-8462/full/v3/i6/177.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i6.177